Archive - January 2020
Elasmogen secures £2m to support next gen biologics
Eli Lilly set to acquire Dermira, including lebrikizumab
ViiV submits fostemsavir MAA to EMA
December NHS stats show wait times ‘worst on record’
FDA starts speedy review of Lynparza plus Avastin in ovarian cancer
BMS expands collaboration with Nektar, sending shares soaring
Bluebird bio launches beta thalassaemia gene therapy Zynteglo in Germany
US start-up EQRx promises approach that will slash drug prices
